<DOC>
	<DOC>NCT00890175</DOC>
	<brief_summary>The purpose of this study is to assess the safety of 2 inhaled doses of Staccato Loxapine within a day in patients with asthma.</brief_summary>
	<brief_title>Staccato Loxapine Pulmonary Safety in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Loxapine</mesh_term>
	<criteria>History of mild to moderate persistent asthma for at least 6 months with prebronchodilator FEV1 â‰¥60% of predicted value. History of COPD, or any other acute or chronic pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Asthma, Staccato loxapine</keyword>
</DOC>